IBD |
Pro-inflammatory effects |
Impaired oxidation of n-butyrate |
Levitt et al., 2002
|
|
|
Patients with UC had excessive SRB colonization or H2S in feces |
Pitcher et al., 2000; Rowan et al., 2009
|
|
Anti-infammatory effects |
Suppression of the activation of NF-kB |
Oh et al., 2006
|
|
|
Promotion of ucler healing in rats |
Wallace et al., 2007b
|
|
|
Downregulation of TNF-α,IFN-γ and iNOS epression |
Li et al., 2007; Wallace et al., 2007a
|
|
|
Contribution to the resolution of experimental colitis |
Wallace et al., 2009
|
|
|
Acting as an antioxidant |
Hirata et al., 2011
|
|
|
Preventation of neutrophil accumulation and viaits anti-oxidant ability |
Hirata et al., 2011
|
|
No effects |
No difference in SRB between patients with IBD and controls |
Fite et al., 2004; Picton et al., 2007
|
CRC |
Carcinogenic factor |
Decrease of suifide-detoxifying enzymes |
Ramasamy et al., 2006
|
|
|
Genomic DNA damage |
Attene-Ramos et al., 2007
|
|
|
Stimulation of the growth and migration |
Cai et al., 2010; Szabo et al., 2013; Modis et al., 2014
|
|
|
Inhibition of cell apoptosis |
Sen et al., 2012
|
|
|
Stimulation of tumor angiogenesis and peritumoral vasodilation |
Szabo et al., 2013
|
|
Cancer suppressive factor |
Reduction of cell viability |
Cao et al., 2010
|
|
|
Inhibition of proliferation and promotion of protective autophagy |
Wu et al., 2012
|